Related Experiment Videos
Vascular lesions following perfusion with bleomycin. Electron-microscopic observations
Virchows Archiv. A, Pathological Anatomy and Histology
|December 27, 1976
Summary
Bleomycin therapy for oral cancer can cause blood vessel damage and microthrombosis, leading to tissue death. These vascular lesions may also contribute to bleomycin-induced lung injury.
Area of Science:
- Oncology
- Vascular Biology
- Pharmacology
Background:
- Intra-arterial bleomycin perfusion is used for oral squamous cell carcinomas.
- Necrotic areas in perfused regions are an observed complication.
Purpose of the Study:
- To investigate the vascular lesions associated with bleomycin perfusion therapy.
- To elucidate the mechanism of microthrombosis formation.
- To explore the implications for treatment efficacy and side effects.
Main Methods:
- Electron microscopy of blood vessels in bleomycin-perfused tumor areas.
- Histopathological analysis of vascular changes.
Main Results:
- Bleomycin caused endothelial cell swelling, vacuolation, and villous projections.
- Arteriolar lesions included endothelial separation, smooth muscle cell swelling, and elastic lamellae destruction.
- These vascular changes were identified as precursors to microthrombosis.
Conclusions:
- Vascular lesions and microthrombosis are key complications of intra-arterial bleomycin perfusion.
- These lesions may negatively impact the anti-cancer effect of bleomycin.
- Vascular damage is implicated in the development of bleomycin-induced lung toxicity.